|
|
| | Larcaviximab Basic information |
| Product Name: | Larcaviximab | | Synonyms: | Larcaviximab;Research Grade Larcaviximab (DVV03601);Research Grade Larcaviximab | | CAS: | 1792982-56-9 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Larcaviximab Structure]() |
| | Larcaviximab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Larcaviximab Usage And Synthesis |
| Uses | Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody[1]. | | References | [1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 30, No. 4, 2016. |
| | Larcaviximab Preparation Products And Raw materials |
|